CONTRAFECT Corp financial data

Symbol
CFRXQ on OTC
Industry
Pharmaceutical Preparations
Location
28 Wells Avenue, 3 Rd Floor, Yonkers, NY
State of incorporation
Delaware
Fiscal year end
December 31

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 84.3 % -64.3%
Debt-to-equity -418 % -483%
Return On Equity 442 %
Return On Assets -139 % -8.38%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10.7M shares -72.8%
Common Stock, Shares, Outstanding 10.7M shares -72.8%
Entity Public Float 121M USD -30.2%
Common Stock, Value, Issued 1K USD -75%
Weighted Average Number of Shares Outstanding, Basic 1.98M shares +279%
Weighted Average Number of Shares Outstanding, Diluted 1.98M shares +279%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 18.5M USD -64%
General and Administrative Expense 11.7M USD -9.13%
Operating Income (Loss) -30.2M USD +58%
Nonoperating Income (Expense) 6.08M USD -50.5%
Net Income (Loss) Attributable to Parent -24.1M USD +59.6%
Earnings Per Share, Basic -0.69 USD/shares +99.4%
Earnings Per Share, Diluted -0.69 USD/shares +99.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.41M USD +16.1%
Marketable Securities, Current 2.03M USD -93.8%
Cash, Cash Equivalents, and Short-term Investments 5.4M USD -69.3%
Other Assets, Current 12K USD -98%
Assets, Current 6.52M USD -67.5%
Property, Plant and Equipment, Net 511K USD -18.6%
Operating Lease, Right-of-Use Asset 1.99M USD -11.6%
Other Assets, Noncurrent 105K USD -2.78%
Assets 9.13M USD -60.4%
Accounts Payable, Current 8.18M USD -46.7%
Accrued Liabilities, Current 3.46M USD -55.4%
Liabilities, Current 12.3M USD -48.2%
Operating Lease, Liability, Noncurrent 1.87M USD -19%
Other Liabilities, Noncurrent 38K USD 0%
Liabilities 14.9M USD -43%
Accumulated Other Comprehensive Income (Loss), Net of Tax -32K USD +61.9%
Retained Earnings (Accumulated Deficit) -340M USD -7.64%
Stockholders' Equity Attributable to Parent -5.76M USD -85.6%
Liabilities and Equity 9.13M USD -60.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -8.8M USD +25.2%
Net Cash Provided by (Used in) Financing Activities 9.01M USD
Net Cash Provided by (Used in) Investing Activities 2.75M USD -42.2%
Common Stock, Shares Authorized 125M shares 0%
Common Stock, Shares, Issued 10.7M shares -72.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.96M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.41M USD +16.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 5K USD
Deferred Tax Assets, Valuation Allowance 106M USD +24.2%
Deferred Tax Assets, Gross 107M USD +23.9%
Operating Lease, Liability 2.55M USD -14.3%
Depreciation 40K USD +5.26%
Payments to Acquire Property, Plant, and Equipment 5K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -24M USD +59.9%
Lessee, Operating Lease, Liability, to be Paid 3.09M USD -18.6%
Property, Plant and Equipment, Gross 4.34M USD +0.93%
Operating Lease, Liability, Current 680K USD +1.95%
Lessee, Operating Lease, Liability, to be Paid, Year Two 721K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 177K USD -75%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 533K USD -34.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 736K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 79.7M USD +2.92%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 750K USD 0%
Additional Paid in Capital 334M USD +6.82%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 758K USD -12.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%